{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:20:32Z","timestamp":1791400832792,"version":"4.3.3"},"reference-count":65,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH\/NIAID","award":["AI080615"],"award-info":[{"award-number":["AI080615"]}]},{"name":"NIH\/NIAID","award":["AR055323"],"award-info":[{"award-number":["AR055323"]}]},{"name":"NIH\/NIAID","award":["N01A060009"],"award-info":[{"award-number":["N01A060009"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.vaccine.2011.05.010","type":"journal-article","created":{"date-parts":[[2011,5,23]],"date-time":"2011-05-23T21:44:32Z","timestamp":1306187072000},"page":"5294-5303","source":"Crossref","is-referenced-by-count":24,"title":["A host-restricted viral vector for antigen-specific immunization against Lyme disease pathogen"],"prefix":"10.1016","volume":"29","author":[{"given":"Sa","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuli","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Akkoyunlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter L.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siba K.","family":"Samal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Utpal","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"December (Pt 12)","key":"10.1016\/j.vaccine.2011.05.010_bib0005","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1099\/0022-1317-74-12-2539","article-title":"RNA editing in Newcastle disease virus","volume":"74","author":"Steward","year":"1993","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2011.05.010_bib0010","series-title":"Fields virology","first-page":"1449","article-title":"Paramyxoviridae: the viruses and their replication","author":"Lamb","year":"2007"},{"issue":"February (1)","key":"10.1016\/j.vaccine.2011.05.010_bib0015","first-page":"46","article-title":"Newcastle disease virus as a vaccine vector for humans","volume":"10","author":"Bukreyev","year":"2008","journal-title":"Curr Opin Mol Ther"},{"issue":"December (1)","key":"10.1016\/j.vaccine.2011.05.010_bib0020","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1006\/viro.2000.0618","article-title":"Recovery of a virulent strain of newcastle disease virus from cloned cDNA: expression of a foreign gene results in growth retardation and attenuation","volume":"278","author":"Krishnamurthy","year":"2000","journal-title":"Virology"},{"issue":"November (21)","key":"10.1016\/j.vaccine.2011.05.010_bib0025","doi-asserted-by":"crossref","first-page":"11560","DOI":"10.1128\/JVI.00713-07","article-title":"Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza virus","volume":"81","author":"DiNapoli","year":"2007","journal-title":"J Virol"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.05.010_bib0030","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/ps\/82.6.899","article-title":"Recombinant Newcastle disease virus as a vaccine vector","volume":"82","author":"Huang","year":"2003","journal-title":"Poult Sci"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.05.010_bib0035","first-page":"945","article-title":"Antitumor effects of Newcastle Disease Virus in vivo: local versus systemic effects","volume":"18","author":"Schirrmacher","year":"2001","journal-title":"Int J Oncol"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2011.05.010_bib0040","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1038\/mt.2008.181","article-title":"Recombinant Newcastle disease virus as a vaccine vector for cancer therapy","volume":"16","author":"Vigil","year":"2008","journal-title":"Mol Ther"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2011.05.010_bib0045","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1128\/JVI.01946-09","article-title":"Newcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge in monkeys","volume":"84","author":"DiNapoli","year":"2010","journal-title":"J Virol"},{"issue":"November (21)","key":"10.1016\/j.vaccine.2011.05.010_bib0050","doi-asserted-by":"crossref","first-page":"13275","DOI":"10.1128\/JVI.79.21.13275-13284.2005","article-title":"Recombinant newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates","volume":"79","author":"Bukreyev","year":"2005","journal-title":"J Virol"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2011.05.010_bib0055","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1128\/JVI.80.3.1130-1139.2006","article-title":"Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector","volume":"80","author":"Martinez-Sobrido","year":"2006","journal-title":"J Virol"},{"issue":"September (17)","key":"10.1016\/j.vaccine.2011.05.010_bib0060","doi-asserted-by":"crossref","first-page":"9366","DOI":"10.1128\/JVI.78.17.9366-9375.2004","article-title":"Induction of cellular immune responses to simian immunodeficiency virus gag by two recombinant negative-strand RNA virus vectors","volume":"78","author":"Nakaya","year":"2004","journal-title":"J Virol"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2011.05.010_bib0065","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1128\/JVI.01443-08","article-title":"Optimization of human immunodeficiency virus gag expression by newcastle disease virus vectors for the induction of potent immune responses","volume":"83","author":"Carnero","year":"2009","journal-title":"J Virol"},{"issue":"June (23)","key":"10.1016\/j.vaccine.2011.05.010_bib0070","doi-asserted-by":"crossref","first-page":"9788","DOI":"10.1073\/pnas.0703584104","article-title":"Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogens","volume":"104","author":"DiNapoli","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"September (18)","key":"10.1016\/j.vaccine.2011.05.010_bib0075","doi-asserted-by":"crossref","first-page":"10054","DOI":"10.1128\/JVI.78.18.10054-10063.2004","article-title":"A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV","volume":"78","author":"Huang","year":"2004","journal-title":"J Virol"},{"issue":"April (18)","key":"10.1016\/j.vaccine.2011.05.010_bib0080","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1016\/j.vaccine.2010.02.051","article-title":"Immunization of cattle with recombinant Newcastle disease virus expressing bovine herpesvirus-1 (BHV-1) glycoprotein D induces mucosal and serum antibody responses and provides partial protection against BHV-1","volume":"28","author":"Khattar","year":"2010","journal-title":"Vaccine"},{"issue":"June (27)","key":"10.1016\/j.vaccine.2011.05.010_bib0085","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1016\/j.vaccine.2010.04.048","article-title":"Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector","volume":"28","author":"Kortekaas","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.05.010_bib0090","series-title":"Borrelia, molecular biology, host interaction and pathogenesis","year":"2010"},{"issue":"April (8)","key":"10.1016\/j.vaccine.2011.05.010_bib0095","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1172\/JCI21681","article-title":"The emergence of Lyme disease","volume":"113","author":"Steere","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2011.05.010_bib0100","series-title":"Borrelia, molecular biology, host interaction and pathogenesis","first-page":"443","article-title":"Detection of Borrelia burgdorferi","author":"Wang","year":"2010"},{"key":"10.1016\/j.vaccine.2011.05.010_bib0105","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1126\/science.2237407","article-title":"Protection of mice against the Lyme disease agent by immunizing with recombinant OspA","volume":"250","author":"Fikrig","year":"1990","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.vaccine.2011.05.010_bib0110","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1056\/NEJM199807233390402","article-title":"A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease","volume":"339","author":"Sigal","year":"1998","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2011.05.010_bib0115","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM199807233390401","article-title":"Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant","volume":"339","author":"Steere","year":"1998","journal-title":"N Engl J Med"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.05.010_bib0120","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/infdis\/175.1.91","article-title":"An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi","volume":"175","author":"Luke","year":"1997","journal-title":"J Infect Dis"},{"issue":"September (25\u201326)","key":"10.1016\/j.vaccine.2011.05.010_bib0125","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1016\/S0264-410X(03)00307-4","article-title":"Evaluation of venezuelan equine encephalitis (VEE) replicon-based outer surface protein A (OspA) vaccines in a tick challenge mouse model of Lyme disease","volume":"21","author":"Gipson","year":"2003","journal-title":"Vaccine"},{"issue":"March (11)","key":"10.1016\/j.vaccine.2011.05.010_bib0130","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.vaccine.2005.10.044","article-title":"Protective efficacy of an oral vaccine to reduce carriage of Borrelia burgdorferi (strain N40) in mouse and tick reservoirs","volume":"24","author":"Scheckelhoff","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.05.010_bib0135","series-title":"Borrelia, molecular biology, host interaction and pathogenesis","first-page":"461","article-title":"Lyme disease vaccines","author":"Marconi","year":"2010"},{"key":"10.1016\/j.vaccine.2011.05.010_bib0140","series-title":"Borrelia, molecular biology, host interaction and pathogenesis","first-page":"353","article-title":"Animal models of borreliosis","author":"Barthold","year":"2010"},{"key":"10.1016\/j.vaccine.2011.05.010_bib0145","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/infdis\/162.1.133","article-title":"Lyme borreliosis in selected strains and ages of laboratory mice","volume":"162","author":"Barthold","year":"1990","journal-title":"J Infect Dis"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2011.05.010_bib0150","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1128\/JCM.20.6.1099-1101.1984","article-title":"Infection of Syrian hamsters with Lyme disease spirochetes","volume":"20","author":"Johnson","year":"1984","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2011.05.010_bib0155","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1749-6632.1988.tb31859.x","article-title":"Experimental infection of the hamster with Borrelia burgdorferi","volume":"539","author":"Johnson","year":"1988","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.vaccine.2011.05.010_bib0160","series-title":"Borrelia, molecular biology, host interaction and pathogenesis","first-page":"413","article-title":"Host response","author":"Weis","year":"2010"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.05.010_bib0165","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrmicro1149","article-title":"The versatile roles of antibodies in Borrelia infections","volume":"3","author":"Connolly","year":"2005","journal-title":"Nat Rev Microbiol"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2011.05.010_bib0170","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1128\/CDLI.12.8.935-940.2005","article-title":"Borrelia burgdorferi BmpA, BmpB, and BmpD proteins are expressed in human infection and contribute to P39 immunoblot reactivity in patients with Lyme disease","volume":"12","author":"Bryksin","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2011.05.010_bib0175","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1084\/jem.20011870","article-title":"An immune evasion mechanism for spirochetal persistence in Lyme borreliosis","volume":"195","author":"Liang","year":"2002","journal-title":"J Exp Med"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.05.010_bib0180","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1084\/jem.20070962","article-title":"Borrelia burgdorferi basic membrane proteins A and B participate in the genesis of Lyme arthritis","volume":"205","author":"Pal","year":"2008","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.vaccine.2011.05.010_bib0185","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1073\/pnas.92.7.2909","article-title":"Induction of an outer surface protein on Borrelia burgdorferi during tick feeding","volume":"92","author":"Schwan","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2011.05.010_bib0190","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1128\/JCM.36.12.3474-3479.1998","article-title":"Peptide-based OspC enzyme-linked immunosorbent assay for serodiagnosis of Lyme borreliosis","volume":"36","author":"Mathiesen","year":"1998","journal-title":"J Clin Microbiol"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2011.05.010_bib0195","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1128\/JCM.35.11.2752-2758.1997","article-title":"Heterogeneity of BmpA (P39) among European isolates of Borrelia burgdorferi sensu lato and influence of interspecies variability on serodiagnosis","volume":"35","author":"Roessler","year":"1997","journal-title":"J Clin Microbiol"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2011.05.010_bib0200","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1128\/IAI.65.11.4661-4667.1997","article-title":"Borrelia burgdorferi strain-specific Osp C-mediated immunity in mice","volume":"65","author":"Bockenstedt","year":"1997","journal-title":"Infect Immun"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.05.010_bib0205","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1128\/IAI.64.6.2234-2239.1996","article-title":"Outer surface protein C (OspC), but not P39, is a protective immunogen against a tick-transmitted Borrelia burgdorferi challenge: evidence for a conformational protective epitope in OspC","volume":"64","author":"Gilmore","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.05.010_bib0210","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1128\/IAI.62.5.1920-1926.1994","article-title":"Protection of C3H\/HeN mice from challenge with Borrelia burgdorferi through active immunization with OspA, OspB or OspC but not OspD or the 83-kilodalton antigen","volume":"62","author":"Probert","year":"1994","journal-title":"Infect Immun"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.05.010_bib0215","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1128\/JVI.2.1.40-47.1968","article-title":"Relationship of plaque size and virulence for chickens of 14 representative Newcastle disease virus strains","volume":"2","author":"Schloer","year":"1968","journal-title":"J Virol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2011.05.010_bib0220","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1128\/IAI.70.4.2139-2150.2002","article-title":"Clonal polymorphism of Borrelia burgdorferi strain B31 MI: implications for mutagenesis in an infectious strain background","volume":"70","author":"Elias","year":"2002","journal-title":"Infect Immun"},{"issue":"March (10)","key":"10.1016\/j.vaccine.2011.05.010_bib0225","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.vaccine.2009.01.009","article-title":"Delivery to the lower respiratory tract is required for effective immunization with Newcastle disease virus-vectored vaccines intended for humans","volume":"27","author":"DiNapoli","year":"2009","journal-title":"Vaccine"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.05.010_bib0230","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1128\/JVI.72.2.891-899.1998","article-title":"synthesis and the requirement for hexamer genome length: the rule of six revisited","volume":"72","author":"Kolakofsky","year":"1998","journal-title":"J Virol"},{"issue":"October (20)","key":"10.1016\/j.vaccine.2011.05.010_bib0235","doi-asserted-by":"crossref","first-page":"8125","DOI":"10.1093\/nar\/15.20.8125","article-title":"An analysis of 5\u2032-noncoding sequences from 699 vertebrate messenger RNAs","volume":"15","author":"Kozak","year":"1987","journal-title":"Nucleic Acids Res"},{"issue":"July (Pt 7)","key":"10.1016\/j.vaccine.2011.05.010_bib0240","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1099\/0022-1317-82-7-1729","article-title":"High-level expression of a foreign gene from the most 3\u2032-proximal locus of a recombinant Newcastle disease virus","volume":"82","author":"Huang","year":"2001","journal-title":"J Gen Virol"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2011.05.010_bib0245","doi-asserted-by":"crossref","first-page":"4999","DOI":"10.1128\/JVI.65.9.4999-5006.1991","article-title":"Neutralization map of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus: domains recognized by monoclonal antibodies that prevent receptor recognition","volume":"65","author":"Iorio","year":"1991","journal-title":"J Virol"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2011.05.010_bib0250","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1172\/JCI200419894","article-title":"OspC facilitates Borrelia burgdorferi invasion of Ixodes scapularis salivary glands","volume":"113","author":"Pal","year":"2004","journal-title":"J Clin Invest"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.05.010_bib0255","doi-asserted-by":"crossref","first-page":"e1000326","DOI":"10.1371\/journal.ppat.1000326","article-title":"A chromosomally encoded virulence factor protects the Lyme disease pathogen against host-adaptive immunity","volume":"5","author":"Yang","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2011.05.010_bib0260","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1128\/IAI.54.3.897-898.1986","article-title":"Active immunization of hamsters against experimental infection with Borrelia burgdorferi","volume":"54","author":"Johnson","year":"1986","journal-title":"Infect Immun"},{"issue":"August (6)","key":"10.1016\/j.vaccine.2011.05.010_bib0265","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/vr.95.6.120","article-title":"A standard haemagglutination inhibition test for Newcastle disease (1). A comparison of macro and micro methods","volume":"95","author":"Allan","year":"1974","journal-title":"Vet Rec"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.05.010_bib0270","doi-asserted-by":"crossref","first-page":"672","DOI":"10.2105\/AJPH.42.6.672","article-title":"An outbreak of conjunctivitis due to Newcastle disease virus (NDV) occurring in poultry workers","volume":"42","author":"Nelson","year":"1952","journal-title":"Am J Public Health Nations Health"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.05.010_bib0275","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1128\/CVI.00431-06","article-title":"Borreliacidal OspC antibody response of canines with Lyme disease differs significantly from that of humans with Lyme disease","volume":"14","author":"Lovrich","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.05.010_bib0280","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1128\/CDLI.12.6.746-751.2005","article-title":"Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human lyme disease and do not occur in mice or hamsters","volume":"12","author":"Lovrich","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2011.05.010_bib0285","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0002-9440(10)63359-7","article-title":"Protective niche for Borrelia burgdorferi to evade humoral immunity","volume":"165","author":"Liang","year":"2004","journal-title":"Am J Pathol"},{"issue":"March (5512)","key":"10.1016\/j.vaccine.2011.05.010_bib0290","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1126\/science.291.5512.2370","article-title":"Glycosylation and the immune system","volume":"291","author":"Rudd","year":"2001","journal-title":"Science"},{"issue":"March (Suppl. 2)","key":"10.1016\/j.vaccine.2011.05.010_bib0295","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1086\/648966","article-title":"Review of meningococcal group B vaccines","volume":"50","author":"Granoff","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"December (11)","key":"10.1016\/j.vaccine.2011.05.010_bib0300","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.4049\/jimmunol.149.11.3648","article-title":"The hamster immune response to tick-transmitted Borrelia burgdorferi differs from the response to needle-inoculated, cultured organisms","volume":"149","author":"Roehrig","year":"1992","journal-title":"J Immunol"},{"issue":"December","key":"10.1016\/j.vaccine.2011.05.010_bib0305","article-title":"The importance of synanthropic wild birds in distribution of Borrelia spirochetes: analysis of spring collections of Ixodes ricinus ticks feeding on passerine birds in the Czech Republic","author":"Dubska","year":"2010","journal-title":"Appl Environ Microbiol"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2011.05.010_bib0310","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1128\/AEM.01674-08","article-title":"Differential role of passerine birds in distribution of Borrelia spirochetes, based on data from ticks collected from birds during the postbreeding migration period in Central Europe","volume":"75","author":"Dubska","year":"2009","journal-title":"Appl Environ Microbiol"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.05.010_bib0315","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3201\/eid1207.060127","article-title":"Migratory passerine birds as reservoirs of Lyme borreliosis in Europe","volume":"12","author":"Comstedt","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"February (4)","key":"10.1016\/j.vaccine.2011.05.010_bib0320","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1128\/AEM.01060-07","article-title":"Blackbirds and song thrushes constitute a key reservoir of Borrelia garinii, the causative agent of borreliosis in Central Europe","volume":"74","author":"Taragel\u2019ova","year":"2008","journal-title":"Appl Environ Microbiol"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.05.010_bib0325","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1128\/AEM.69.5.2825-2830.2003","article-title":"Association of Borrelia garinii and B. valaisiana with songbirds in Slovakia","volume":"69","author":"Hanincova","year":"2003","journal-title":"Appl Environ Microbiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11007080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11007080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T23:55:08Z","timestamp":1686095708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11007080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":65,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0264410X11007080"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.05.010","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}